IDEXX Labs (IDXX) Tops Q4 EPS by 20c ; Offers Guidance

IDEXX Labs (NASDAQ: IDXX) reported Q4 EPS of $2.32, $0.20 better than the analyst estimate of $2.12. Revenue for the quarter came in at $901.6 million versus the consensus estimate of $891.08 million.

GUIDANCE:

IDEXX Labs sees FY2024 EPS of $10.84-$11.33, versus the consensus of $11.00. IDEXX Labs sees FY2024 revenue of $3.93-4.04 billion, versus the consensus of $3.97 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.

You May Also Be Interested In

• Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
• Okta, Inc. (OKTA) Tops Q2 EPS by 8c; offers guidance
• Donaldson (DCI) Tops Q4 EPS by 2c ; Offers Guidance